Viewing Study NCT00104858

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2026-01-24 @ 9:30 PM
Study NCT ID: NCT00104858
Status: COMPLETED
Last Update Posted: 2019-07-11
First Post: 2005-03-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: Fred Hutchinson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Prolymphocytic Leukemia View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Stage III Chronic Lymphocytic Leukemia View
None Stage III Small Lymphocytic Lymphoma View
None Stage IV Chronic Lymphocytic Leukemia View
None Stage IV Small Lymphocytic Lymphoma View
None T-Cell Large Granular Lymphocyte Leukemia View
Keywords: